You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms, Plasma Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Plasma Cell Leukemia
  • CAR-T (CAR-GPRC5D)
  • Wuhan, Hu Bei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
May 17, 2022

Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Plasma Cell Tumor Trial in Atlanta (Pneumococcal 13-valent Conjugate Vaccine, Trivalent Influenza Vaccine)

Active, not recruiting
  • Plasma Cell Neoplasm
  • Pneumococcal 13-valent Conjugate Vaccine
  • Trivalent Influenza Vaccine
  • Atlanta, Georgia
  • +1 more
Jan 24, 2022

Multiple Myeloma Trial in Wuhan (Plasma-free procedure)

Completed
  • Multiple Myeloma
  • Plasma-free procedure
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Feb 10, 2022

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Recruiting
  • Multiple Myeloma
  • +11 more
  • No intervention
  • Beijing, China
    Peking University First Hospital
Apr 21, 2022

Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill

Recruiting
  • Multiple Myeloma
  • +8 more
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital
    Nov 30, 2021

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)

    Active, not recruiting
    Has Results
    • Advanced Lymphoma
    • +5 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 28, 2022

    Immunophenotyping of Plasma Cells and Immune Effector Cells in

    Not yet recruiting
    • Multiple Myeloma
    • Biological sampling
    • (no location specified)
    Jun 17, 2022

    Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

    Not yet recruiting
    • Lymphoma
    • +2 more
    • Web Application
    • San Francisco, California
      University of California, San Francisco
    Aug 9, 2022

    Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

    Recruiting
    • Lymphoid Leukemia, Acute
    • +2 more
    • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc
    May 24, 2022

    Based on Maintenance Therapy Post Autologous Stem Cell

    Recruiting
    • Multiple Myeloma
    • Autologous Stem Cell Transplant
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jul 27, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Trametinib Dimethyl Sulfoxide
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Aug 13, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Defactinib

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Defactinib Hydrochloride
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 28, 2022

    Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

    Not yet recruiting
    • Neoplasm, Plasma Cell
    • Lymphoma
    • Comprehensive Geriatric Assessment
    • Toulouse, France
      University Hospital Toulouse
    May 17, 2022

    ctDNA Methylation Sequencing for Myeloma

    Recruiting
    • Multiple Myeloma
    • plasma circulation DNA methylation sequencing
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    Oct 11, 2022

    Multiple Myeloma Trial in Saint Petersburg (Melphalan, Nivolumab, Autologous Stem Cell Transplantation)

    Recruiting
    • Multiple Myeloma
    • Saint Petersburg, Russian Federation
      Boris V Afanasyev, MD, Prof.
    Apr 4, 2022

    Multiple Myeloma, Tumors, Tumors, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • +7 more
    • Belantamab Mafodotin-Blmf
    • +3 more
    • (no location specified)
    Mar 4, 2022

    Myeloma Multiple Trial (Traditional Control, Oral Nutritional Supplement)

    Not yet recruiting
    • Myeloma Multiple
    • Traditional Control
    • Oral Nutritional Supplement
    • (no location specified)
    Jul 12, 2022

    Plasma Cell Myeloma, Transplant-Related Carcinoma Trial in Seattle (Ixazomib Citrate, Laboratory Biomarker Analysis,

    Active, not recruiting
    Has Results
    • Plasma Cell Myeloma
    • Transplant-Related Carcinoma
    • Ixazomib Citrate
    • +2 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center
    Jul 12, 2022

    The Indiana Myeloma Registry

    Recruiting
    • Plasma Cell Dyscrasias
    • This is a non-interventional trial
    • Indianapolis, Indiana
      Indiana University Simon Cancer Center
    Mar 2, 2022

    Multiple Myeloma Trial in Houston (Belantamab mafodotin)

    Not yet recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Portland (Carfilzomib, Isatuximab, Pomalidomide)

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jun 14, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Laboratory Biomarker Analysis, Lenalidomide,

    Completed
    Has Results
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Laboratory Biomarker Analysis
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Dec 1, 2021

    Stratification in Multiple Myeloma Based on Fluorescence Flow

    Recruiting
    • Myeloma Multiple
    • fluorescence flow cytometry
    • Saint Petersburg, Russian Federation
      Boris V Afanasyev, MD, Prof.
    Jul 19, 2022

    Multiple Myeloma, Plasma Cell Disorder Trial in Germany, United States (HDP-101)

    Recruiting
    • Multiple Myeloma
    • Plasma Cell Disorder
    • Atlanta, Georgia
    • +5 more
    Mar 10, 2022